Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group
  2. Taxonomy
  3. Term
  4. Cell and Gene Therapy

A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History Study

Go back to Resources

A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History Study

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Exposure to Agent Orange and Association with Myelodysplastic Syndromes

Go back to Resources

Exposure to Agent Orange and Association with Myelodysplastic Syndromes

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Go back to Resources

Cellular and Gene Therapy

  • Read more about Cellular and Gene Therapy

Recruiting and Retaining Patients in Sickle Cell Disease Trials

  • Read more about Recruiting and Retaining Patients in Sickle Cell Disease Trials

Mental health challenges associated with sickle cell disease and strategies to address them: Reflections from a community input panel

Go back to Resources

Mental health challenges associated with sickle cell disease and strategies to address them: Reflections from a community input panel

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature

Go back to Resources

The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Challenges and limitations of mobilization and stem cell collection for gene therapy of sickle cell disease

Go back to Resources

Challenges and limitations of mobilization and stem cell collection for gene therapy of sickle cell disease

Authors:

Volume:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Assessing Psychosocial Risk and Resilience to Support Readiness for Gene Therapy in Sickle Cell Disease: A Consensus Statement

Go back to Resources

Assessing Psychosocial Risk and Resilience to Support Readiness for Gene Therapy in Sickle Cell Disease: A Consensus Statement

Authors:

Volume:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Pancreatic Islet Transplantation: CITR Update

Go back to Resources

Pancreatic Islet Transplantation: CITR Update

Authors:

URL:

Go back to Resources

04-2: Role of Immunosuppression and TNF-Alpha Inhibition in Outcomes of Islet-alone and Islet-after-Kidney Transplantation: Report from The Collaborative Islet Transplant Registry

Go back to Resources

04-2: Role of Immunosuppression and TNF-Alpha Inhibition in Outcomes of Islet-alone and Islet-after-Kidney Transplantation: Report from The Collaborative Islet Transplant Registry

Authors:

Volume:

Pagination:

Issue:

Journal:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Pagination

  • Page 1
  • Next page ››
Subscribe to Cell and Gene Therapy
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification